At-home Healthcare And Workflow Automation Will Expand Patient Reach

Published
24 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$13.50
8.1% undervalued intrinsic discount
14 Aug
US$12.41
Loading
1Y
-4.5%
7D
1.1%

Author's Valuation

US$13.5

8.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 38%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget has increased revenue growth from 8.6% to 9.5%, increased profit margin from 6.2% to 9.5% and decreased future PE multiple from 26.1x to 16.6x.

Shared on09 Apr 25
Fair value Increased 67%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 39%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 69%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 2.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.